|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Arava (leflunomide) Tablets, 10 mg, 20 mg, and 100 mg, Aventis NDA 20-905/S6/S7 6/13/03 7/8/03 7/8/03 Arava (leflunomide) Tablets, 10 mg, 20 mg, and 100 mg, Hoechst Marion Roussel NDA 20-905 9/10/98 9/17/98 9/17/98 5/25/01 Arava Indication: Arava is indicated in adults for the treatment of active rheumatoid arthritis (RA) to reduce signs and symptoms and to retard structural damage as evidenced by X-ray erosions and joint space narrowing. Arava (leflunomide) Tablets, Aventis Pharmaceuticals | Arava (leflunomide) tablets, Aventis Pharma, Labeling Revision | Leflunomide Tablets, Teva Pharma, Approval | Leflunomide Tablets, Sandoz, Approval | Leflunomide Tablets, Barr Labs, Approval | Leflunomide Tablets, Kali Labs, Approval | Leflunomide Tablets, Sandoz, Approval | Leflunomide Tablets, Apotex, Approval | Arava (leflunomide tablets), Sanofi-Aventis, Labeling Revision
|